NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis
暂无分享,去创建一个
Ji Luo | David F. Stroncek | Chi Ma | Dean W. Felsher | Ping Jin | David E. Kleiner | Daniel W. McVicar | Aparna H. Kesarwala | D. Felsher | T. Greten | M. Heikenwalder | D. Kleiner | Ji Luo | D. Stroncek | Chi Ma | Miaojun Han | V. Kapoor | P. Jin | Mathias Heikenwalder | M. Terabe | Tim F. Greten | A. Weber | Veena Kapoor | Miaojun Han | Masaki Terabe | J. Medina-Echeverz | Achim Weber | Angela M. Thornton | Tobias Eggert | José Medina-Echeverz | Mei ElGindi | Haibo Zhang | Michèle Egger | D. McVicar | A. Kesarwala | A. Thornton | T. Eggert | Mei ElGindi | Haibo Zhang | Michèle Egger | J. Medina‐Echeverz | A. Weber
[1] R. Green,et al. Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet , 2008 .
[2] A. Rehman,et al. Dendritic cells limit fibroinflammatory injury in nonalcoholic steatohepatitis in mice , 2013, Hepatology.
[3] A. Diehl,et al. NAFLD, NASH and liver cancer , 2013, Nature Reviews Gastroenterology &Hepatology.
[4] T. Koves,et al. Measurement of fatty acid oxidation rates in animal tissues and cell lines. , 2014, Methods in enzymology.
[5] E. Niki,et al. Involvement of free radicals and oxidative stress in NAFLD/NASH , 2013, Free radical research.
[6] Richard A. Flavell,et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity , 2012, Nature.
[7] L. Wojtczak,et al. Fatty acids as modulators of the cellular production of reactive oxygen species. , 2008, Free radical biology & medicine.
[8] H. Moch,et al. Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes. , 2014, Cancer cell.
[9] R. F. Chen,et al. Removal of fatty acids from serum albumin by charcoal treatment. , 1967, The Journal of biological chemistry.
[10] H. Cai,et al. Interferon-α activates multiple STAT signals and down-regulates c-Met in primary human hepatocytes , 2002 .
[11] A. Wree,et al. From NAFLD to NASH to cirrhosis—new insights into disease mechanisms , 2013, Nature Reviews Gastroenterology &Hepatology.
[12] M. Manns,et al. A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells. , 2008, Gastroenterology.
[13] O. Cummings,et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.
[14] H. Daniel,et al. Metabolite profiling in plasma and tissues of ob/ob and db/db mice identifies novel markers of obesity and type 2 diabetes , 2015, Diabetologia.
[15] H. Cai,et al. Interferon-alpha activates multiple STAT signals and down-regulates c-Met in primary human hepatocytes. , 2002, Gastroenterology.
[16] R. Siegel,et al. Extracellular flux analysis to monitor glycolytic rates and mitochondrial oxygen consumption. , 2014, Methods in enzymology.
[17] D. Schuppan,et al. Non‐alcoholic steatohepatitis: Pathogenesis and novel therapeutic approaches , 2013, Journal of gastroenterology and hepatology.
[18] M. Manns,et al. Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma. , 2013, Journal of hepatology.
[19] Jun Hee Lee,et al. Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression , 2010, Cell.
[20] J. Rathmell,et al. Metabolic Reprogramming towards Aerobic Glycolysis Correlates with Greater Proliferative Ability and Resistance to Metabolic Inhibition in CD8 versus CD4 T Cells , 2014, PloS one.
[21] J. Castle,et al. Mutant MHC class II epitopes drive therapeutic immune responses to cancer , 2015, Nature.
[22] M. Taniguchi,et al. CD4(+) Valpha14 natural killer T cells are essential for acceptance of rat islet xenografts in mice. , 2000, The Journal of clinical investigation.
[23] Christopher H. Contag,et al. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer , 2004, Nature.
[24] R. Ravi,et al. A high‐fat diet and regulatory T cells influence susceptibility to endotoxin‐induced liver injury , 2007, Hepatology.
[25] S. Ostrand-Rosenberg,et al. Gr-1+ CD11b+ Myeloid-derived Suppressor Cells Suppress Inflammation and Promote Insulin Sensitivity in Obesity* , 2011, The Journal of Biological Chemistry.
[26] S. Hazen,et al. Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis[S] , 2010, Journal of Lipid Research.
[27] D. Brenner,et al. Toll‐like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice , 2013, Hepatology.
[28] P. Schirmacher,et al. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. , 2018, Journal of hepatology.
[29] Kavya Rakhra,et al. CD4(+) T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivation. , 2010, Cancer cell.
[30] X. Wang,et al. Current concepts of immune based treatments for patients with HCC: from basic science to novel treatment approaches , 2015, Gut.
[31] T. Luedde,et al. Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury , 2011, Gut.
[32] T. Copetti,et al. A mitochondrial switch promotes tumor metastasis. , 2014, Cell reports.
[33] E. Seki,et al. Transforming growth factor beta signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in mice , 2014, Hepatology.
[34] C. Trautwein,et al. Pharmacological IKK2 inhibition blocks liver steatosis and initiation of non-alcoholic steatohepatitis , 2008, Gut.
[35] T. Luedde,et al. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development , 2011, Nature.
[36] T. Greten,et al. Hepatocellular Carcinoma from an Immunologic Perspective , 2013, Clinical Cancer Research.
[37] L. Beretta,et al. Proteomic and lipidomic signatures of lipid metabolism in NASH-associated hepatocellular carcinoma. , 2013, Cancer research.
[38] M. Karin,et al. Obesity, inflammation, and liver cancer. , 2012, Journal of hepatology.
[39] F. Middleton,et al. Prevention of hepatocarcinogenesis and increased susceptibility to acetaminophen-induced liver failure in transaldolase-deficient mice by N-acetylcysteine. , 2009, The Journal of clinical investigation.
[40] E. Shevach,et al. CD4+FoxP3+ regulatory T cells confer infectious tolerance in a TGF-β–dependent manner , 2008, The Journal of experimental medicine.
[41] M. Karin,et al. ER stress cooperates with hypernutrition to trigger TNF-dependent spontaneous HCC development. , 2014, Cancer cell.